MTND4P17: A Drug Target / Disease Biomarker (G100873242)

Target Name: MTND4P17

NCBI ID: G100873242

MTND4P17

Other Name(s): Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 17 | MT-ND4 pseudogene 17

MTND4P17: A Drug Target / Disease Biomarker

MTND4P17 is a protein that is expressed in the brain and is known for its role in the development and progression of multiple sclerosis (MS). The protein is made by a gene called MTND4P17 and is found in the brain, heart, and muscle.

One of the things that makes MTND4P17 so interesting as a drug target is its role in the development and progression of MS. MS is a chronic and debilitating disease that affects the central nervous system and can cause a range of symptoms, including muscle weakness, vision problems, and fatigue. Currently, there is no cure for MS and there are only treatments that can slow down the progression of the disease.

MTND4P17 has been shown to be involved in the development and progression of MS by regulating the activity of immune cells in the brain. Studies have shown that people with MS have increased levels of immune cells in the brain, and that these cells are involved in the destruction of the protective covering of nerve fibers called myelin.

In addition, MTND4P17 has also been shown to be involved in the regulation of pain signaling in the brain. People with MS often experience chronic pain, and this pain can be difficult to manage. Studies have shown that MTND4P17 plays a role in the regulation of pain signaling in the brain and that this protein may be a useful target for pain treatments.

Another aspect of MTND4P17 that makes it an interesting drug target is its role in the regulation of inflammation in the brain. MS is often associated with chronic inflammation in the brain, and this inflammation can contribute to the development and progression of the disease.

MTND4P17 has been shown to be involved in the regulation of inflammation in the brain by helping to reduce the production of pro-inflammatory molecules. This is important because chronic inflammation in the brain can contribute to the development and progression of MS, and may also contribute to the development of other neurological conditions.

In conclusion, MTND4P17 is a protein that is expressed in the brain and is known for its role in the development and progression of MS. This protein has been shown to be involved in the regulation of immune cells, pain signaling, and inflammation in the brain. As a result, MTND4P17 is an attractive target for drug development for MS and other neurological conditions.

Protein Name: MT-ND4 Pseudogene 17

The "MTND4P17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTND4P17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets